Prognostic value of imaging-detected immune-related adverse events in biliary tract cancer patients receiving durvalumab-based chemotherapy - Poll - MDSpire

Prognostic value of imaging-detected immune-related adverse events in biliary tract cancer patients receiving durvalumab-based chemotherapy

  • By

  • Jeongin Yoo

  • Dong Ho Lee

  • Do-Youn Oh

  • Jeesun Yoon

  • Sang Hyub Lee

  • In Rae Cho

  • Woo Hyun Paik

  • May 28, 2026

  • 0 min

Share

Original Source(s)

Prognostic value of imaging-detected immune-related adverse events in biliary tract cancer patients receiving durvalumab-based chemotherapy

  • by Jeongin Yoo, Dong Ho Lee, Do-Youn Oh, Jeesun Yoon, Sang Hyub Lee, In Rae Cho, Woo Hyun Paik

  • May 28, 2026

Related Content

A Case Report of follicular dendritic cell sarcoma

2026 AACR Bladder Cancer Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the bladder cancer clinical updates you need to know from AACR 2026.

  • June 17, 2026

  • 1 min
Malignant transformation of uterine serosal endometriosis to clear cell carcinoma in a postmenopausal patient: a rare case report